https://medicaex.com/prnewswire/hayashibara-brings-back-trehalose-symposium-to-reveal-its-game-changing-versatilities-in-human-biochemistry/ 2022-10-06T06:00:37+00:00 https://medicaex.com/prnewswire/duality-announced-the-appointment-of-dr-yver-as-chairman-of-sab/ 2022-10-06T06:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/10/1-qnkLQ3.jpeg https://medicaex.com/prnewswire/synergen-health-recognized-with-five-consecutive-great-place-to-work-accolades-in-2022/ 2022-10-05T14:00:14+00:00 https://medicaex.com/wp-content/uploads/2022/10/SYNERGEN_Health_2022_Best_Workplaces_Asia_Logo-8GtMeo.jpeg https://medicaex.com/prnewswire/ascletis-announces-dosing-of-the-first-patient-in-phase-ii-clinical-trial-of-thr%ce%b2-agonist-asc41-for-52-week-treatment-of-liver-biopsy-proven-nash/ 2022-10-05T01:00:24+00:00 https://medicaex.com/prnewswire/estrella-biopharma-inc-a-biopharmaceutical-company-to-become-a-publicly-traded-company-via-merger-with-tradeup-acquisition-corp/ 2022-10-05T00:00:25+00:00 https://medicaex.com/prnewswire/kira-pharmaceuticals-receives-fda-clearance-of-ind-application-for-phase-2-evaluation-of-kp104-in-systemic-lupus-erythematosus-associated-thrombotic-microangiopathy-sle-tma/ 2022-10-05T00:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/10/Kira_Pharmaceuticals_Logo-LKOxwo.jpeg https://medicaex.com/prnewswire/img-appoints-amanda-winkle-as-chief-operating-officer/ 2022-10-04T14:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/International_Medical_Group_Logo-vgmEB7.jpeg https://medicaex.com/prnewswire/debiopharm-reinforces-the-bond-between-swiss-and-japanese-cancer-research-with-the-2022-jca-mauvernay-award-ceremony/ 2022-10-04T13:00:26+00:00 https://medicaex.com/prnewswire/targedys-and-inoliva-announce-they-have-entered-a-distribution-partnership-to-bring-satylia-to-turkey/ 2022-10-04T11:00:36+00:00 https://medicaex.com/wp-content/uploads/2022/10/TargEDys_Inoliva_Logo-CGMOn6.jpeg https://medicaex.com/prnewswire/qilian-international-holding-group-limited-reports-financial-results-for-the-first-six-months-of-fiscal-year-2022/ 2022-10-04T11:00:22+00:00 https://medicaex.com/prnewswire/ghas-healthstars-excelerator-driving-business-and-healthcare-outcomes-through-innovation/ 2022-10-04T11:00:20+00:00 https://medicaex.com/wp-content/uploads/2022/10/Global_Healthcare_Accreditation-Fm66yy.jpeg https://medicaex.com/prnewswire/mentice-ab-publ-receives-an-order-of-usd-620000-for-simulation-solutions-and-development-services/ 2022-10-04T08:00:44+00:00 https://medicaex.com/prnewswire/cambrex-announces-stability-storage-expansions-in-ireland-and-belgium/ 2022-10-04T08:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/10/Cambrex_Logo-CBZiMn.jpeg https://medicaex.com/prnewswire/infinitus-products-received-the-hong-kong-q-mark-certificate/ 2022-10-04T06:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/10/9________Q-HPJTh5.jpeg https://medicaex.com/prnewswire/ys-biopharma-to-merge-with-nasdaq-listed-summit-healthcare-acquisition-corp/ 2022-10-03T14:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/YS_Biopharma_Summit_Healthcare_Logo-4mHgMS.jpeg https://medicaex.com/prnewswire/agilis-robotics-targeting-its-pre-b-round-fund-raising-to-be-completed-by-2022/ 2022-10-03T12:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/10/Surgical_robotic_arm_developed_by_Agilis_Robotics-x6pxI4.jpeg https://medicaex.com/prnewswire/doxy-me-extends-telemedicines-reach-to-88-of-the-worlds-population/ 2022-10-03T11:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/10/Horizontal_Black_Margins__4x_Logo-aDK5QS.jpeg https://medicaex.com/prnewswire/samsung-biologics-introduces-new-development-platforms-s-dual-and-developick-at-bpi-boston-2022/ 2022-10-03T07:00:25+00:00 https://medicaex.com/prnewswire/axa-launches-medienhancer-supplement/ 2022-10-03T07:00:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/AXA_Launches__MediEnhancer_Supplement-STvAkg.jpeg https://medicaex.com/prnewswire/angel-pharmaceuticals-announces-approval-of-ind-application-for-phase-1-1b-clinical-trial-of-mupadolimab-anti-cd73-in-china/ 2022-10-03T01:00:56+00:00 https://medicaex.com/prnewswire/neushen-therapeutics-closes-pre-a-financing-with-20m/ 2022-10-03T01:00:40+00:00 https://medicaex.com/wp-content/uploads/2022/10/Dr_Joan_Shen_Founder_CEO_Neushen_Therapeutics-H9m2o9.jpeg https://medicaex.com/prnewswire/bon-natural-life-limited-provides-update-on-its-expansion-project/ 2022-09-30T21:00:16+00:00 https://medicaex.com/prnewswire/lunit-showcases-ai-solutions-for-radiology-at-aocr-kcr-2022/ 2022-09-30T20:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/10/Visitors_gather_Lunit_s_booth_AOCR___KCR_2022-wfrWl9.jpeg https://medicaex.com/prnewswire/siyi-intelligence-successfully-exhibited-syrebo-rehabilitation-products-at-rehacare-2022/ 2022-09-30T17:00:48+00:00 https://medicaex.com/wp-content/uploads/2022/10/1-vcLh6Y.jpeg https://medicaex.com/prnewswire/simcere-and-almirall-enter-into-a-licensing-agreement-for-il-2-mu-fc/ 2022-09-30T17:00:39+00:00 https://medicaex.com/prnewswire/green-mountain-biotech-and-kamedis-announce-first-patent-in-china-for-unique-herb-based-acne-and-skin-relief-solution/ 2022-09-30T11:00:34+00:00 https://medicaex.com/prnewswire/niaid-nih-recognizes-the-potency-of-ub-421-against-multi-drug-resistant-hiv-and-receives-the-fda-approval-to-conduct-a-phase-2-clinical-trial-with-ub-421/ 2022-09-30T04:00:21+00:00 https://medicaex.com/prnewswire/wel-bloom-launches-delicious-jelly-supplement-edibles-a-new-milestone-in-dietary-supplement-manufacturer/ 2022-09-30T03:00:30+00:00 https://medicaex.com/prnewswire/green-mountain-biotech-and-kamedis-announce-first-patent-in-china-for-unique-herb-based-acne-and-skin-relief-solution-2/ 2022-09-29T20:00:25+00:00 https://medicaex.com/prnewswire/first-patient-in-new-zealand-dosed-with-illuccix-telixs-prostate-cancer-imaging-agent/ 2022-09-29T19:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/09/Telix_Logo-aLuqs2.jpeg https://medicaex.com/prnewswire/gc-labs-becomes-the-first-korean-laboratory-to-obtain-certification-of-cdc-standardization-programs-vdscp-host/ 2022-09-29T18:00:43+00:00 https://medicaex.com/wp-content/uploads/2022/09/GC_Labs_Logo-2TAAlU.jpeg https://medicaex.com/prnewswire/climate-change-and-health-inequity-a-deadly-mix-for-the-most-vulnerable-world-heart-federation/ 2022-09-29T14:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/09/World_Heart_Federation-cjiJNS.jpeg https://medicaex.com/prnewswire/united-imaging-and-carrollton-regional-medical-center-accelerate-installation-of-the-revolutionary-uct-atlas-scanner/ 2022-09-29T13:00:36+00:00 https://medicaex.com/prnewswire/zhongchao-inc-establishes-chongqing-xinjiang-pharmaceutical-co-ltd-to-improve-patient-access-to-medications/ 2022-09-29T13:00:25+00:00 https://medicaex.com/prnewswire/generations-connect-project-brings-young-people-together-with-the-elderly-to-boost-emotional-resilience/ 2022-09-29T10:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/09/Photo_1-71ildq.jpeg https://medicaex.com/prnewswire/ability-diabetes-global-a-landmark-rct-in-the-field-of-pci-for-patients-with-dm-completes-enrolment/ 2022-09-29T09:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/09/Ability_Diabetes_Global-hyBLnQ.jpeg https://medicaex.com/prnewswire/first-patient-enrolled-in-prostact-target-study/ 2022-09-29T06:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/09/Telix_Logo-E8h24T.jpeg https://medicaex.com/prnewswire/singapore-smes-triumph-against-new-challenges/ 2022-09-29T04:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/Congratulations_to_the_Winners_of_2022_Singapore_SME100-MCTyoE.jpeg https://medicaex.com/prnewswire/samsung-biologics-earns-gold-rating-from-ecovadis-for-its-sustainability-efforts/ 2022-09-29T03:00:40+00:00 https://medicaex.com/prnewswire/wuxi-biologics-topped-off-the-steel-on-its-commercial-biomanufacturing-facility-in-worcester-massachusetts/ 2022-09-29T03:00:30+00:00 https://medicaex.com/prnewswire/pharming-announces-us-fda-acceptance-for-priority-review-of-its-new-drug-application-for-leniolisib/ 2022-09-28T22:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/09/Pharming_Group_NV_Logo-5pR8BL.jpeg https://medicaex.com/prnewswire/astrum-005-the-first-immunotherapy-clinical-study-of-sclc-published-in-jama-one-of-the-top-medical-journals-in-the-world/ 2022-09-28T14:00:22+00:00 https://medicaex.com/prnewswire/first-ever-spinal-surgical-hand-held-robot-by-point-robotics-medtech-to-make-its-worldwide-debut-in-the-united-states/ 2022-09-28T14:00:11+00:00 https://medicaex.com/wp-content/uploads/2022/09/Photo_1__POINT__Kinguide_Robotic_Assisted_Surgical_System_makes_its_debut_in_the_United_States-7qlef5.jpeg https://medicaex.com/prnewswire/chugai-pharma-taiwan-awarded-at-the-asia-responsible-enterprise-awards-2022-for-cycling-for-charity-under-social-empowerment-category/ 2022-09-28T13:00:29+00:00 https://medicaex.com/prnewswire/bioheng-biotech-announces-publication-of-impressive-results-with-cd7-targeted-allogeneic-car-t-cell-therapy-for-relapsed-or-refractory-t-cell-malignancies/ 2022-09-28T12:00:55+00:00 https://medicaex.com/prnewswire/mediaseeks-proprietary-neurofeedback-engine-alpha-switch-and-its-smartphone-application-mentioned-in-international-journal/ 2022-09-28T12:00:48+00:00 https://medicaex.com/prnewswire/the-ind-application-of-biosyngen-brg01-therapy-was-accepted-by-cde/ 2022-09-28T11:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/09/Biosyngen_Logo-QCTDKQ.jpeg https://medicaex.com/prnewswire/the-6th-china-shenzhen-innovation-entrepreneurship-international-competition-eindhoven-netherlands-division-is-open-for-registration/ 2022-09-28T11:00:16+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-announces-presentation-of-wearable-sensor-data-from-the-biomuse-natural-history-study-at-the-international-congress-of-parkinsons-disease-and-movement-disorders/ 2022-09-28T10:00:43+00:00 https://medicaex.com/wp-content/uploads/2022/09/Alterity_Logo-sXZ2fV.jpeg https://medicaex.com/prnewswire/metabolon-expands-data-access-strategy-to-include-health-for-life-in-singapore-helios-study/ 2022-09-28T10:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/Metabolon_Inc_Logo-WJGPt0.jpeg https://medicaex.com/prnewswire/new-gha-certification-helps-medical-tourism-facilitators-build-patient-trust/ 2022-09-28T10:00:24+00:00 https://medicaex.com/prnewswire/biosyngen-gives-cell-therapy-gmp-capabilities-in-singapore-a-boost/ 2022-09-28T10:00:22+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_5006429_18988015-I996Zb.jpeg https://medicaex.com/prnewswire/daiichi-sankyo-joins-startup-creaspheres-program-powered-by-plug-and-play/ 2022-09-28T09:00:17+00:00 https://medicaex.com/wp-content/uploads/2022/09/PNP_Logo-bELNhX.jpeg https://medicaex.com/prnewswire/kotra-call-indonesian-companies-to-boost-economic-cooperation/ 2022-09-28T04:00:15+00:00 https://medicaex.com/prnewswire/ascletis-announces-dosing-of-the-first-patient-in-the-phase-iib-expansion-cohort-of-asc22-envafolimab-for-chronic-hepatitis-b-functional-cure/ 2022-09-28T01:00:35+00:00 https://medicaex.com/prnewswire/aahrpp-accredits-five-more-research-organizations-including-first-in-japan/ 2022-09-27T23:00:51+00:00 https://medicaex.com/wp-content/uploads/2022/09/aahrpp_logo-m0eFPz.jpeg https://medicaex.com/prnewswire/tct2022-pulnovo-medical-announced-that-the-latest-results-of-padn-cfda-pivotal-trial-indicate-effectiveness-and-safety-of-padn-for-the-treatment-of-pulmonary-arterial-hypertension-pah/ 2022-09-27T21:00:53+00:00 https://medicaex.com/wp-content/uploads/2022/09/PADN_ON_THE_WAY-ia9o3M-scaled.jpeg https://medicaex.com/prnewswire/fosun-pharma-and-maia-pharmaceuticals-jointly-announce-the-successful-commercialization-of-only-fda-approved-20ml-sodium-phenylacetate-and-sodium-benzoate-spsb-liquid-product/ 2022-09-27T21:00:38+00:00 https://medicaex.com/prnewswire/rvac-medicines-initiates-first-in-human-clinical-trials-for-mrna-covid-19-vaccine-candidates/ 2022-09-27T17:00:47+00:00 https://medicaex.com/prnewswire/love-your-heart-event-to-offer-tips-on-overall-and-heart-health/ 2022-09-27T17:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/09/FPH_MLC_Logo_DIGITAL-TFV9l4.jpeg https://medicaex.com/prnewswire/cp-kelco-partners-with-exopolymer-to-bring-next-generation-functional-biopolymers-to-market/ 2022-09-27T14:00:16+00:00 https://medicaex.com/wp-content/uploads/2022/09/CP_Kelco_ExoPolymer-AXD1gN.jpeg https://medicaex.com/prnewswire/ascentage-pharma-announces-phase-i-ii-data-of-olverembatinib-hqp1351-published-in-the-journal-of-hematology-oncology-further-validating-the-drugs-best-in-class-potential/ 2022-09-27T13:01:25+00:00 https://medicaex.com/wp-content/uploads/2022/09/Ascentage_Pharma_Logo-Gj7CiT.jpeg https://medicaex.com/prnewswire/charsires-new-drug-aims-to-capture-multi-billion-dollar-dementia-treatment-market/ 2022-09-27T12:00:53+00:00 https://medicaex.com/wp-content/uploads/2022/09/Charsire_Photo_220921-AXV2TE.jpeg https://medicaex.com/prnewswire/wuxi-sta-opens-first-high-potency-oral-drug-product-manufacturing-facility/ 2022-09-27T12:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_1-obcwo7.jpeg https://medicaex.com/prnewswire/in-commemoration-of-world-pharmacists-day-2022-pg-health-lauds-pharmacists-and-the-role-they-play-in-providing-whole-of-body-healthcare-to-patients/ 2022-09-27T12:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/09/image1-KBkjWK.jpeg https://medicaex.com/prnewswire/pharmabcine-to-participate-in-bio-europe-2022/ 2022-09-27T11:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/PharmAbcineLogo-YmGcB0.jpeg https://medicaex.com/prnewswire/amaris-b-clinic-awarded-the-body-sculpting-medical-centre-of-the-year-in-asia-pacific-for-four-years-in-a-row-by-globalhealth-asia-pacific/ 2022-09-27T10:00:24+00:00 https://medicaex.com/prnewswire/ivory-dentin-grafttm-the-first-and-only-dentin-graft-receives-ce-mark/ 2022-09-27T09:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/09/Ivory_Graft_Logo-55WJFz.jpeg https://medicaex.com/prnewswire/brii-biosciences-announces-top-line-results-from-phase-1-study-of-brii-296-a-long-acting-therapy-in-development-for-postpartum-depression/ 2022-09-27T09:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-oRovv3.jpeg https://medicaex.com/prnewswire/how-healthcare-organizations-can-enhance-a-holistic-patient-and-member-view-by-improving-insights-from-data/ 2022-09-27T08:00:16+00:00 https://medicaex.com/prnewswire/sciwind-biosciences-and-synerk-enter-into-research-partnership-to-discover-and-develop-novel-sirna-therapeutics/ 2022-09-27T01:00:38+00:00 https://medicaex.com/prnewswire/luye-pharma-enters-local-seroquel-distribution-and-marketing-partnership-with-ici-pakistan-limited/ 2022-09-27T01:00:38+00:00 https://medicaex.com/wp-content/uploads/2022/09/Image1-rtxIxb.jpeg https://medicaex.com/prnewswire/gmp-cell-cdmo-i-peace-inc-in-collaboration-with-universities-successfully-converted-human-dermal-fibroblasts-into-oligodendrocyte-by-direct-reprogramming/ 2022-09-27T00:00:58+00:00 https://medicaex.com/wp-content/uploads/2022/09/image-jm4Ypt.jpeg https://medicaex.com/prnewswire/nippon-express-china-participates-in-11th-global-pharmaceutical-cold-chain-summit/ 2022-09-27T00:00:40+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-receives-u-s-fda-approval-for-investigational-new-drug-application-for-ath434-for-the-treatment-of-multiple-system-atrophy/ 2022-09-26T21:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/09/Alterity_Logo-6vk0V2.jpeg https://medicaex.com/prnewswire/axa-betterme-weekend-comes-back-on-8-to-9-october/ 2022-09-26T16:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/09/AXA_BetterMe_Weekend_Site_Map-zhZIf3.jpeg https://medicaex.com/prnewswire/pulnovo-medical-released-results-from-padn-cfda-pivotal-trial-for-the-treatment-of-pulmonary-arterial-hypertension-pah/ 2022-09-26T15:00:38+00:00 https://medicaex.com/prnewswire/cellorigin-biotech-announces-global-strategic-collaboration-with-qilu-pharma-to-develop-off-the-shelf-car-imac-cell-therapy/ 2022-09-26T14:00:25+00:00 https://medicaex.com/prnewswire/new-treatment-for-rare-cancer-cholangiocarcinoma-approved-in-australia/ 2022-09-26T13:01:07+00:00 https://medicaex.com/prnewswire/everest-medicines-receives-approval-of-investigational-new-drug-application-from-china-nmpa-for-ever001-a-novel-btk-inhibitor-in-development-for-treatment-of-renal-diseases/ 2022-09-26T13:00:49+00:00 https://medicaex.com/prnewswire/j-ints-bio-poster-presentation-of-further-preclinical-data-of-its-novel-oral-4th-generation-egfr-tki-jin-a02-at-the-2022-european-society-for-medical-oncology-congress-in-paris-france-esmo-2022/ 2022-09-26T11:00:55+00:00 https://medicaex.com/wp-content/uploads/2022/09/JINTS_Photo-6y6rcO.jpeg https://medicaex.com/prnewswire/111-inc-announces-appointment-of-independent-financial-advisor-and-legal-counsel-to-the-special-committee/ 2022-09-26T11:00:40+00:00 https://medicaex.com/prnewswire/smithnephew-launches-or3o-dual-mobility-system-in-japan-for-use-in-primary-and-revision-hip-arthroplasty/ 2022-09-26T07:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/09/Smith_Nephew_OR3O-goCTqC.jpeg https://medicaex.com/prnewswire/shandong-proton-center-celebrates-milestone-in-delivering-high-quality-proton-treatment/ 2022-09-26T07:00:31+00:00 https://medicaex.com/prnewswire/winners-of-the-2023-breakthrough-prizes-in-life-sciences-mathematics-and-fundamental-physics-announced/ 2022-09-26T07:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/09/Breakthrough-Dpr4eE.jpeg https://medicaex.com/prnewswire/cellresearch-corporation-crc-to-present-promising-new-stem-cell-products-for-the-treatment-of-chronic-diabetic-foot-ulcers-at-the-worlds-premier-diabetic-foot-conference-dfcon-in-los-angeles/ 2022-09-26T06:00:23+00:00 https://medicaex.com/wp-content/uploads/2022/09/CellResearch_Corporation_Logo-v5pWe9.jpeg https://medicaex.com/prnewswire/china-cde-grants-cmg901-breakthrough-therapy-designation-for-claudin-18-2-positive-advanced-gastric-gastroesophageal-junction-cancer/ 2022-09-26T04:00:38+00:00 https://medicaex.com/prnewswire/i-mab-announces-approval-from-china-cde-to-initiate-phase-3-registrational-study-of-lemzoparlimab-in-combination-with-azacitidine-in-higher-risk-myelodysplastic-syndrome/ 2022-09-23T17:00:54+00:00 https://medicaex.com/wp-content/uploads/2022/09/logo_Logo-TuCUcr.jpeg https://medicaex.com/prnewswire/first-and-only-tigit-tgf-%ce%b2-dual-targeting-antibody-fusion-protein-of-akeso-demonstrated-promise-in-preclinical-results-published-at-esmo/ 2022-09-23T12:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/09/logo_Logo-TKsXUN.jpeg https://medicaex.com/prnewswire/mgi-launches-ultra-high-speed-dnbseq-g99-gene-sequencer-with-mid-to-low-range-throughput/ 2022-09-23T10:00:40+00:00 https://medicaex.com/prnewswire/histosonics-announces-published-results-of-phase-i-liver-tumor-trial/ 2022-09-23T06:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/09/HistoSonics_Image_of_Edison_system-gDcnbc.jpeg https://medicaex.com/prnewswire/heads-of-state-commit-to-noncommunicable-disease-global-compact-to-save-50-million-lives-by-2030/ 2022-09-23T06:00:24+00:00 https://medicaex.com/wp-content/uploads/2022/09/Bloomberg_Philanthropies_Logo-80oTpr.jpeg https://medicaex.com/prnewswire/usana-philippines-earns-three-major-awards-for-corporate-excellence/ 2022-09-23T02:00:17+00:00 https://medicaex.com/wp-content/uploads/2022/09/USANA_Logo-M6fWCb.jpeg https://medicaex.com/prnewswire/cellenkos-receives-fda-clearance-of-investigational-new-drug-ind-application-for-ck0803-for-the-treatment-of-amyotrophic-lateral-sclerosis-als/ 2022-09-22T13:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/09/Stacked_3x-kVRosu.jpeg https://medicaex.com/prnewswire/frost-sullivan-explores-the-growing-impact-of-the-digital-front-door-on-healthcare/ 2022-09-22T10:00:27+00:00 https://medicaex.com/wp-content/uploads/2022/09/Digital_Front_Door__Think_tank-ycqBIc.jpeg https://medicaex.com/prnewswire/nia-accelerates-thai-foodtech-startups-to-steer-bangkok-towards-becoming-foodtech-silicon-valley-through-space-f-project/ 2022-09-22T09:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/09/NIA_continues_its_support_in_scaling_up_the_FoodTech_startups-S8Yu1Q.jpeg https://medicaex.com/prnewswire/clarivate-supports-peer-review-week-by-raising-the-profile-of-peer-reviewers/ 2022-09-22T08:00:17+00:00 https://medicaex.com/wp-content/uploads/2022/09/Clarivate_Logo-Ljj2Jf.jpeg https://medicaex.com/prnewswire/magictouch-scb-receives-ide-approval-for-in-stent-restenosis-indication/ 2022-09-22T06:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/09/MagicTouch-KR5Ct4.jpeg https://medicaex.com/prnewswire/starpharma-presents-compelling-data-in-prostate-cancer-at-esmo/ 2022-09-22T02:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/09/Starpharma_table-oQdMgl.jpeg https://medicaex.com/prnewswire/i-mab-announces-positive-phase-2-data-of-lemzoparlimab-in-combination-with-azacitidine-aza-in-patients-with-higher-risk-myelodysplastic-syndrome-at-esmo-2022/ 2022-09-21T15:00:59+00:00 https://medicaex.com/wp-content/uploads/2022/09/logo_Logo-vlAwY3.jpeg https://medicaex.com/prnewswire/sirnaomics-to-present-latest-developments-on-sirna-therapeutics-for-cancer-and-galaheadtm-platform-programs-at-the-2nd-annual-oligonucleotide-therapeutics-and-delivery-conference/ 2022-09-21T15:00:43+00:00 https://medicaex.com/prnewswire/the-fifth-ciie-is-ready-to-open-its-door-to-worldwide-participants/ 2022-09-21T14:00:34+00:00 https://medicaex.com/wp-content/uploads/2022/09/CIIE_1-2OyLzy.jpeg https://medicaex.com/prnewswire/vivitro-labs-introduces-worlds-first-set-it-and-forget-it-heart-valve-durability-tester/ 2022-09-21T13:00:36+00:00 https://medicaex.com/wp-content/uploads/2022/09/ViVitro_Labs_Inc__ViVitro_Labs_Introduces_World_s_first__Set_it-4b2GSx.jpeg https://medicaex.com/prnewswire/jdrf-announces-launch-of-global-type-1-diabetes-index/ 2022-09-21T13:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/jdrf_logo-ELOhKO.jpeg https://medicaex.com/prnewswire/far-eastern-new-century-won-the-sustainability-innovation-award-from-itmf-awards-2022-with-fenc-topgreen-bio3/ 2022-09-21T13:00:16+00:00 https://medicaex.com/wp-content/uploads/2022/09/FENC_R_D_photo-l54WNi.jpeg https://medicaex.com/prnewswire/first-patient-enrolled-in-erectile-dysfunction-prospective-randomized-study-with-selution-slr/ 2022-09-21T12:00:58+00:00 https://medicaex.com/wp-content/uploads/2022/09/MedAlliance_Image-AiDGAt.jpeg https://medicaex.com/prnewswire/wuxi-biologics-drug-substance-and-drug-product-facilities-again-approved-by-u-s-fda-and-ema/ 2022-09-21T12:00:41+00:00 https://medicaex.com/prnewswire/menarini-and-sciclone-sign-exclusive-licensing-agreement-to-develop-and-commercialize-vaborem-in-china-to-treat-antimicrobial-resistant-infections/ 2022-09-21T12:00:40+00:00 https://medicaex.com/wp-content/uploads/2022/09/SciClone_logo-kZO5h7.jpeg https://medicaex.com/prnewswire/new-study-in-jnccn-suggests-way-to-predict-outcomes-with-high-accuracy-prior-to-surgery-for-pancreatic-cancer-patients/ 2022-09-21T10:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/09/NCCN_Logo-5mtWyZ.jpeg https://medicaex.com/prnewswire/the-6th-china-health-and-senior-care-conference-held-in-southwest-chinese-city-shizhu/ 2022-09-21T10:00:17+00:00 https://medicaex.com/prnewswire/unstoppable-rise-of-korean-medical-tourism/ 2022-09-21T09:00:22+00:00 https://medicaex.com/wp-content/uploads/2022/09/Image-9FswuQ.jpeg https://medicaex.com/prnewswire/united-imaging-announces-clinical-system-installations-at-huntsman-cancer-institute-at-the-university-of-utah/ 2022-09-21T06:00:32+00:00 https://medicaex.com/prnewswire/new-study-by-lunit-and-mgh-validates-effectiveness-of-ai-as-aid-in-chest-x-ray-interpretation-published-in-jama-network-open/ 2022-09-21T05:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/09/Lunit_CI_Logo-NimtNS.jpeg https://medicaex.com/prnewswire/remegen-announces-preliminary-results-of-phase-iii-confirmatory-study-of-telitacicept-for-treatment-of-systemic-lupus-erythematosus-sle-in-china/ 2022-09-21T05:00:23+00:00 https://medicaex.com/prnewswire/excelra-partners-with-patcore-inc/ 2022-09-21T05:00:13+00:00 https://medicaex.com/wp-content/uploads/2022/09/Excelra_Logo-3omtzl.jpeg https://medicaex.com/prnewswire/u-s-fda-grants-emergency-use-authorization-for-novavax-covid-19-vaccine-adjuvanted-for-adolescents-aged-12-through-17/ 2022-09-21T02:00:17+00:00 https://medicaex.com/wp-content/uploads/2022/09/Novavax_High_Res_Logo-Ll3UxB.jpeg https://medicaex.com/prnewswire/final-ipax-1-study-data-confirms-safety-and-tolerability-profile-for-tlx101-preliminary-efficacy-data/ 2022-09-21T01:00:36+00:00 https://medicaex.com/wp-content/uploads/2022/09/Telix_Logo-ehXTLt.jpeg https://medicaex.com/prnewswire/special-interview-with-dr-patrick-yu-wai-man-on-international-lhon-awareness-day/ 2022-09-21T00:00:40+00:00 https://medicaex.com/prnewswire/amare-global-announces-acquisition-of-kyani-inc/ 2022-09-21T00:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/HorizontalLogo_Tagline_RGB_01_Logo-r1DY0w.jpeg https://medicaex.com/prnewswire/pulnovo-medical-concludes-successfully-the-first-steering-committee-meeting/ 2022-09-20T21:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/09/1-RwbJYp.jpeg https://medicaex.com/prnewswire/dimagi-receives-25-million-to-develop-transformative-technology-for-frontline-workers/ 2022-09-20T13:00:12+00:00 https://medicaex.com/prnewswire/transform-1-enrollment-completed-a-crucial-rct-ready-to-redefine-the-dcb-angioplasty-mechanism/ 2022-09-20T12:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/09/TRANSFORM_1_Enrollment-mFKuPS.jpeg https://medicaex.com/prnewswire/hummingbird-bioscience-announces-trial-in-progress-poster-presentation-at-the-european-society-for-medical-oncology-congress-2022/ 2022-09-20T11:00:37+00:00 https://medicaex.com/prnewswire/anyong-biotechnologys-locally-sourced-sante-silver-perch-essence-fulfilling-increasing-demand-in-the-apac-wellness-industry/ 2022-09-20T11:00:21+00:00 https://medicaex.com/prnewswire/jialian-biotech-group-to-participate-at-vitafoods-asia-2022-in-bangkok/ 2022-09-20T07:00:12+00:00 https://medicaex.com/prnewswire/antengene-announces-atg-101-granted-orphan-drug-designation-by-the-u-s-fda/ 2022-09-20T03:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/ANTENGENE_EN_Logo-CKqJ7P.jpeg https://medicaex.com/prnewswire/everest-medicines-appoints-rogers-yongqing-luo-as-chief-executive-officer-to-lead-next-stage-of-company-growth/ 2022-09-20T00:00:39+00:00 https://medicaex.com/prnewswire/smartfutures-white-label-remote-patient-monitoring-platform-goes-global/ 2022-09-19T23:00:29+00:00 https://medicaex.com/prnewswire/waterdrop-launches-the-wfind-system/ 2022-09-19T15:00:13+00:00 https://medicaex.com/prnewswire/hummingbird-bioscience-chief-scientific-officer-jerome-boyd-kirkup-to-present-at-the-2nd-annual-vista-virtual-symposium/ 2022-09-19T13:00:18+00:00 https://medicaex.com/prnewswire/microtech-to-unveil-implantable-microsensor-technology-at-34th-transcatheter-cardiovascular-therapeutics-tct-annual-meeting/ 2022-09-19T12:00:49+00:00 https://medicaex.com/wp-content/uploads/2022/09/Medinol_Logo-YLktrs.jpeg https://medicaex.com/prnewswire/sirtex-medical-secures-positive-approval-of-sir-spheres-y-90-resin-microspheres-for-hcc-treatment-in-brazil/ 2022-09-19T12:00:41+00:00 https://medicaex.com/wp-content/uploads/2022/09/Sirtex_Medical_Logo-AEiNgu.jpeg https://medicaex.com/prnewswire/hexvix-a-diagnostic-drug-of-asieris-is-now-covered-by-the-2022-lecheng-global-specialty-drug-insurance/ 2022-09-19T11:00:23+00:00 https://medicaex.com/prnewswire/taiwans-anyong-biotechnology-first-to-employ-seafood-stem-cell-freezing/ 2022-09-19T09:00:13+00:00 https://medicaex.com/prnewswire/dietary-leader-einfit-builds-a-healthy-lifestyle-with-award-winning-supplements/ 2022-09-19T09:00:13+00:00 https://medicaex.com/prnewswire/austar-lifesciences-announces-2022-interim-results/ 2022-09-19T08:00:21+00:00 https://medicaex.com/prnewswire/who-is-hussain-world-record-smashed-as-british-charity-recruits-over-37000-blood-donors-on-single-day/ 2022-09-19T05:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/09/Medical_staff_and_volunteers-862kNH.jpeg https://medicaex.com/prnewswire/massimo-calafiore-appointed-as-new-limacorporate-ceo/ 2022-09-19T04:00:45+00:00 https://medicaex.com/prnewswire/bioworld-by-clarivate-adds-laser-focused-preclinical-research-news-into-new-fully-integrated-platform/ 2022-09-19T04:00:37+00:00 https://medicaex.com/wp-content/uploads/2022/09/Clarivate_Logo-XkZybv.jpeg https://medicaex.com/prnewswire/sifi-to-present-new-scientific-data-and-launch-a-new-intraocular-lens-during-the-40th-congress-of-the-european-society-of-cataract-and-refractive-surgeons/ 2022-09-19T01:00:40+00:00 https://medicaex.com/wp-content/uploads/2022/09/SIFI_Logo-kIVljj.jpeg https://medicaex.com/prnewswire/menarini-groups-elacestrant-marketing-authorization-application-accepted-for-review-by-the-european-medicines-agency-ema-for-the-treatment-of-er-her2-advanced-or-metastatic-breast-cancer/ 2022-09-18T10:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/09/MENARINI_Group_Logo-ntTUBN.jpeg https://medicaex.com/prnewswire/worlds-first-car-t-for-nmosd-treatment-iaso-biotherapeutics-equecabtagene-autoleucel-receives-ind-approval-by-nmpa/ 2022-09-18T10:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-7MmZ5S.jpeg https://medicaex.com/prnewswire/novavax-nuvaxovid-covid-19-vaccine-granted-expanded-provisional-approval-in-new-zealand-for-adolescents-aged-12-through-17/ 2022-09-17T13:00:28+00:00 https://medicaex.com/wp-content/uploads/2022/09/Novavax_High_Res_Logo-jumd5n.jpeg https://medicaex.com/prnewswire/the-fifth-ciie-is-to-broaden-scope-for-belt-and-road-countries/ 2022-09-16T19:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/09/CIIE-28M4s7.jpeg https://medicaex.com/prnewswire/seekin-receives-ce-mark-approval-for-oncoseek-multi-cancer-detection-test/ 2022-09-16T18:00:36+00:00 https://medicaex.com/prnewswire/cellresearch-corporation-crc-announces-positive-results-of-phase-i-study-for-corlicyte/ 2022-09-16T17:00:39+00:00 https://medicaex.com/prnewswire/brain-navi-biotechnology-announced-partnership-with-distributor-medtreq-medical-equipment-to-enter-the-middle-east-and-egypt-with-naotrac-neurosurgical-robot/ 2022-09-16T16:00:39+00:00 https://medicaex.com/wp-content/uploads/2022/09/Brain_Navi_Biotechnology_Announced_Partnership_Distributor_Metreq_Medical_Equipment-TP7mbh.jpeg https://medicaex.com/prnewswire/genscript-receives-best-cell-gene-therapy-supplier-award-gene-editing-and-genscript-probio-receives-best-biologics-cmo-awards-upstream-processing-analytical-services/ 2022-09-16T16:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/09/Dr_Leo_Li_Marketing_Director_GenScript_Asia_Pacific_division_receiving-YqIXIA.jpeg https://medicaex.com/prnewswire/novavax-nuvaxovid-covid-19-vaccine-granted-expanded-provisional-approval-in-new-zealand-as-a-first-and-second-booster-for-adults/ 2022-09-16T11:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/09/Novavax_High_Res_Logo-8g5N8G.jpeg https://medicaex.com/prnewswire/mgi-celebrates-grand-opening-of-its-new-state-of-the-art-demo-lab-in-japan/ 2022-09-16T10:00:48+00:00 https://medicaex.com/prnewswire/juniper-biologics-establishes-global-headquarters-in-singapore/ 2022-09-16T10:00:36+00:00 https://medicaex.com/prnewswire/inxmed-announces-first-patient-dosed-in-phase-2-pivotal-study-of-in10018-in-patients-with-platinum-resistant-recurrent-ovarian-cancer/ 2022-09-15T13:00:49+00:00 https://medicaex.com/wp-content/uploads/2022/09/InxMed_Logo-eRYGLc.jpeg https://medicaex.com/prnewswire/havas-health-you-appoints-laura-mizrahi-chief-creative-officer-of-flagship-agency-h4b-chelsea/ 2022-09-15T13:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/HH_Y_Logo_Logo-af9bSb.jpeg https://medicaex.com/prnewswire/shanghai-public-health-clinical-center-completed-patient-enrollment-in-clinical-study-of-pd-l1-antibody-asc22-envafolimab-in-combination-with-chidamide-for-functional-cure-of-hiv-infection/ 2022-09-15T11:00:24+00:00 https://medicaex.com/prnewswire/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences/ 2022-09-15T10:00:32+00:00 https://medicaex.com/wp-content/uploads/2022/09/gracell_logo_Logo-7y9kjl.jpeg https://medicaex.com/prnewswire/axa-hong-kong-and-hsbc-jointly-launch-helpershield-insurance/ 2022-09-15T10:00:15+00:00 https://medicaex.com/prnewswire/fosun-foreign-media-reports-about-regulatory-authorities-asking-banks-to-examine-their-exposure-to-fosun-are-completely-false/ 2022-09-15T09:00:30+00:00 https://medicaex.com/prnewswire/transcenta-received-ind-clearance-from-fda-for-its-first-in-class-gremlin1-targeting-antibody-tst003-for-the-treatment-of-solid-tumors/ 2022-09-15T09:00:30+00:00 https://medicaex.com/prnewswire/food-pioneers-sophies-bionutrients-and-newfish-join-forces-to-develop-dairy-alternatives-from-microalgae/ 2022-09-15T09:00:17+00:00 https://medicaex.com/wp-content/uploads/2022/09/Sophie_s_Bionutrients_Microalgae_Milk_alternative-Jbhpaw.jpeg https://medicaex.com/prnewswire/nippon-express-obtains-gdp-certification-of-compliance-with-who-standards-at-east-japan-pharmaceutical-center/ 2022-09-15T08:00:25+00:00 https://medicaex.com/prnewswire/dr-catherine-mohr-to-join-board-of-medtech-company-aroa-biosurgery/ 2022-09-15T07:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/09/image1-fuWKf8.jpeg https://medicaex.com/prnewswire/global-study-shows-artificial-intelligence-can-reduce-time-to-pregnancy-for-ivf-couples-by-12/ 2022-09-15T06:00:44+00:00 https://medicaex.com/prnewswire/md-anderson-and-radiopharm-theranostics-launch-joint-venture-to-develop-novel-radiopharmaceuticals/ 2022-09-15T06:00:25+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-ok4ilW.jpeg https://medicaex.com/prnewswire/data-from-kn046-in-patients-with-metastatic-nsclc-who-failed-first-line-treatment-or-prior-egfr-tkis-presented-at-esmo-2022/ 2022-09-15T04:00:26+00:00 https://medicaex.com/prnewswire/alphamab-oncology-presents-the-updated-data-from-phase-2-clinical-trial-on-kn046-combined-with-platinum-doublet-chemotherapy-as-first-line%ef%bc%881l%ef%bc%89treatment-for-nsclc-at-esmo-2022/ 2022-09-15T02:00:40+00:00 https://medicaex.com/prnewswire/nutromics-raises-us14-million-for-its-ground-breaking-wearable-diagnostic-platform/ 2022-09-14T13:00:47+00:00 https://medicaex.com/wp-content/uploads/2022/09/F_Di_0650_copy-SG5xNR.jpeg https://medicaex.com/prnewswire/debiopharm-co-leads-a-10m-usd-series-a-round-to-accelerate-the-development-of-genomic-medicines-through-artificial-intelligence/ 2022-09-14T13:00:32+00:00 https://medicaex.com/prnewswire/introducing-crown-aesthetics-international-educational-program-for-skinpen-precision-customers/ 2022-09-14T07:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/09/Crown_Logo-Wb9Xut.jpeg https://medicaex.com/prnewswire/edgc-eone-diagnomics-genome-center-recruits-sam-martin-vice-president-of-overseas-business-development-to-accelerate-entering-the-overseas-market/ 2022-09-14T06:00:33+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_1-BiG31H.jpeg https://medicaex.com/prnewswire/turn-biotechnologies-launches-eturna-delivery-platform-designed-specifically-to-enable-nucleic-acid-therapeutics/ 2022-09-14T05:00:44+00:00 https://medicaex.com/prnewswire/updated-data-presented-for-kn026-combokn046-in-1st-line-her2-positive-gastric-gastroesophageal-junction-cancer-gc-gej/ 2022-09-14T02:00:35+00:00 https://medicaex.com/prnewswire/gbb-lands-usd-15m-pre-series-b-funding-led-by-tiger-jade-capital/ 2022-09-14T02:00:31+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_5012991_44917397-Y2NjEz.jpeg https://medicaex.com/prnewswire/ao-foundation-acquires-rimasys-to-advance-the-surgical-education-ecosystem-of-the-future/ 2022-09-14T01:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/09/AO_RIMASYS_Logos-DWkc8L.jpeg https://medicaex.com/prnewswire/antengene-unveils-its-first-australian-office-to-continue-expanding-global-presence/ 2022-09-14T01:00:26+00:00 https://medicaex.com/wp-content/uploads/2022/09/Members_Antengene_s_Australia_team_work_newly_opened_office-PhlQbh.jpeg https://medicaex.com/prnewswire/tikomeds-ilbr-inhibits-cell-infection-by-coronaviruses-and-modulates-reactive-cytokine-release-from-microglia-in-vitro/ 2022-09-14T00:00:45+00:00 https://medicaex.com/prnewswire/lunit-to-showcase-5-abstracts-at-esmo-2022/ 2022-09-13T14:01:00+00:00 https://medicaex.com/wp-content/uploads/2022/09/Lunit_CI_Logo-h5IuHF.jpeg https://medicaex.com/prnewswire/transcenta-releases-encouraging-interim-safety-and-efficacy-data-of-the-tst001-osemitamab-and-chemotherapy-combination-expansion-cohort-for-first-line-claudin18-2-positive-gastric-cancer-at-esmo-con/ 2022-09-13T13:00:30+00:00 https://medicaex.com/prnewswire/genfleet-therapeutics-to-present-data-from-phase-i-trial-of-gfh018-monotherapy-at-the-2022-european-society-for-medical-oncology-annual-meeting/ 2022-09-13T12:01:08+00:00 https://medicaex.com/prnewswire/nccns-new-patient-guidelines-for-marginal-zone-lymphoma-help-patients-and-caregivers-better-understand-a-rare-form-of-blood-cancer/ 2022-09-13T12:00:45+00:00 https://medicaex.com/wp-content/uploads/2022/09/mzl-hRTXCp.jpeg https://medicaex.com/prnewswire/independent-scientific-study-demonstrates-pfas-is-not-identified-or-leached-in-ipackchem-advanced-in-mold-fluorinated-containers/ 2022-09-13T12:00:29+00:00 https://medicaex.com/wp-content/uploads/2022/09/IPACKCHEM_Logo-KUKkeJ.jpeg https://medicaex.com/prnewswire/globalhealth-asia-pacific-recognises-amaris-b-clinic-as-the-gynecomastia-clinic-of-the-year-in-asia-pacific-2022/ 2022-09-13T10:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/09/IMAGE-Y3TTqT.jpeg https://medicaex.com/prnewswire/fda-approved-investigator-initiated-pre-market-clinical-trial-of-lambre-plus-laa-closure-system-obtained-medical-insurance-coverage-in-the-us/ 2022-09-13T08:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/09/Logo-kYn1L0.jpeg https://medicaex.com/prnewswire/epivax-secures-additional-funding-from-fda-for-immunogenicity-risk-assessment-for-biosimilar-products/ 2022-09-13T08:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/09/EpiVax_Logo-BJ4maE.jpeg https://medicaex.com/prnewswire/non-invasive-skin-immune-biomarker-test-helps-predict-development-of-eczema-in-babies-new-study-presented-at-the-eadv-congress-finds/ 2022-09-13T06:01:01+00:00 https://medicaex.com/prnewswire/himalaya-therapeutics-announces-interim-phase-2-results-for-mecbotamab-vedotin-htba3011/ 2022-09-13T06:00:42+00:00 https://medicaex.com/wp-content/uploads/2022/09/himalaya_therapeutics_Logo-YVI2rC.jpeg https://medicaex.com/prnewswire/venus-medtech-announces-2022-interim-results-quality-and-efficiency-improvement-profitability-focus-rapid-progress-in-global-presence/ 2022-09-13T01:00:52+00:00 https://medicaex.com/wp-content/uploads/2022/09/image_821354_39486828-2UFXWb.jpeg https://medicaex.com/prnewswire/cstone-announces-chinas-nmpa-has-accepted-and-granted-priority-review-to-the-supplemental-new-drug-application-snda-for-sugemalimab-in-the-treatment-of-patients-with-relapsed-or-refractory-extrano/ 2022-09-13T01:00:40+00:00 https://medicaex.com/prnewswire/laekna-announces-first-patient-dosed-in-south-korea-in-lae201int2101-phase-1-2-study/ 2022-09-12T22:00:58+00:00 https://medicaex.com/prnewswire/darwinhealth-publication-reports-step-by-step-protocol-for-its-tumor-checkpoint-based-compound-to-clinic-c2c-cancer-drug-discovery-pipeline-elucidates-a-patient-to-model-to-patient-pmp-roadmap-f/ 2022-09-12T17:00:46+00:00 https://medicaex.com/wp-content/uploads/2022/09/DarwinHealth_Logo-dorNFE.jpeg https://medicaex.com/prnewswire/rapidai-applauded-by-frost-sullivan-for-delivering-quality-care-quickly-and-securely-with-its-rapidai-platform/ 2022-09-12T17:00:35+00:00 https://medicaex.com/prnewswire/the-eco-friendly-anti-nausea-and-vomiting-wristband-emeterm-plus/ 2022-09-12T16:01:04+00:00 https://medicaex.com/wp-content/uploads/2022/09/ET_plus_3-L2C8hu.jpeg https://medicaex.com/prnewswire/broncus-02216-hk-announced-interim-results/ 2022-09-12T16:01:04+00:00 https://medicaex.com/prnewswire/111-inc-receives-unsolicited-preliminary-non-binding-proposal-to-acquire-the-company/ 2022-09-12T16:00:49+00:00 https://medicaex.com/prnewswire/wuxi-sta-opens-a-new-sterile-lipid-nanoparticle-formulation-facility-to-enhance-global-crdmo-services-for-customers/ 2022-09-12T16:00:48+00:00 https://medicaex.com/wp-content/uploads/2022/09/LNP-yFSURn.jpeg https://medicaex.com/prnewswire/prenetics-announces-second-quarter-2022-financial-results-and-raises-full-year-adjusted-ebitda-outlook/ 2022-09-12T16:00:48+00:00 https://medicaex.com/prnewswire/redbud-raises-10m-in-series-a-round-as-cro-focusing-on-science-driven-clinical-development/ 2022-09-12T16:00:47+00:00 https://medicaex.com/prnewswire/esmo-2022-great-oaks-grow-from-small-acorns-oncology-is-committed-to-doing-its-part-for-sustainability/ 2022-09-12T16:00:47+00:00 https://medicaex.com/prnewswire/fdi-world-dental-federation-launches-toolkit-on-how-to-make-dentistry-more-sustainable/ 2022-09-12T16:00:33+00:00 https://medicaex.com/prnewswire/antengene-to-present-at-upcoming-industry-conferences/ 2022-09-12T15:00:30+00:00 https://medicaex.com/wp-content/uploads/2022/09/ANTENGENE_EN_Logo-JE0u6v.jpeg https://medicaex.com/prnewswire/nuralogix-researchers-announce-ai-models-that-can-predict-blood-biomarker-risk/ 2022-09-12T13:00:44+00:00 https://medicaex.com/wp-content/uploads/2022/09/NuraLogix_Corporation_NuraLogix_researchers_announce_AI_models_t-pU1RVD.jpeg